Molecular mechanisms underlying skeletal growth arrest by cutaneous scarring

Jingtao Li1, Chelsey A Johnson2, Andrew A Smith3

  • 1Department of Oral and Maxillofacial Surgery, West China Stomatology Hospital, Chengdu 610041, China; Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford School of Medicine, Stanford CA 94035, USA.

Bone
|June 17, 2014
PubMed

Insights

Scarring after pediatric surgery can halt bone growth. This study shows scar contracture generates forces that inhibit vertebral growth, leading to permanent shortening and emphasizing early scar reduction.

Area of Science:

  • Biomedical Engineering
  • Developmental Biology
  • Skeletal Biology

Background:

  • Pediatric surgery often results in cutaneous scarring, which is linked to impaired skeletal growth.
  • The underlying molecular mechanisms connecting scar contracture to osteogenesis remain largely unknown.

Purpose of the Study:

  • To investigate the relationship between scar contracture and osteogenesis in pediatric bone growth.
  • To elucidate the mechanical and cellular effects of scarring on vertebral development.

Main Methods:

  • Excisional cutaneous wounding in neonatal mice tails.
  • Finite element (FE) modeling to predict contractile forces and strain distribution.
  • Micro-computed tomography (micro-CT) analysis of vertebral morphogenesis.
  • Assays for cell proliferation, death, differentiation, and matrix remodeling in growth plates and intervertebral discs (IVDs).

Main Results:

  • Wound contracture led to significant tail shortening and localized compressive strains in vertebral growth plates and IVDs.
  • These strains correlated with increased cell death, reduced proliferation, and impaired mineralization.
  • Vertebrae remained significantly shorter post-scarring, even after contracture resolution and normalized growth rates.

Conclusions:

  • Localized contractile forces from cutaneous scarring inhibit pediatric bone growth by altering cellular processes in a site-specific manner.
  • Scar-induced bone growth inhibition is permanent, as compensatory growth does not occur.
  • Early intervention to reduce scar contracture is crucial for preserving pediatric skeletal growth after surgery.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
31
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
49